BeBvacizumab treatment leads to observable morphological and metabolic changes in brain radiation necrosis

Journal of Neuro-Oncology

Volumn 119, Issue 1, 2014, Pages 101-109

  Yonezawa, Shingo ^a,b   Miwa, Kazuhiro ^a,b   Shinoda, Jun ^a,b   Nomura, Yuichi ^a,b   Asano, Yoshitaka ^a,b   Nakayama, Noriyuki ^b   Ohe, Naoyuki ^b   Yano, Hirohito ^b   Iwama, Toru ^b  

^a Kizawa Memorial Hospital   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

Bevacizumab; Magnetic resonance imaging; Magnetic resonance spectroscopy; Positron emission tomography; Radiation necrosis

Indexed keywords

BEVACIZUMAB; CHOLINE; CHOLINE C 11; CREATINE; GADOLINIUM PENTETATE; METHIONINE C 11; VASCULOTROPIN; MONOCLONAL ANTIBODY;

ADULT; AMINO ACID TRANSPORT; ANEMIA; ARTERIAL THROMBOEMBOLISM; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN HEMORRHAGE; BRAIN LESION NORMAL TISSUE RATIO; BRAIN METABOLISM; BRAIN METASTASIS; BRAIN NECROSIS; CHOLINE CREATINE RATIO; CHOLINE UPTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC TEST ACCURACY STUDY; DRUG MECHANISM; FEMALE; GLIOBLASTOMA; HUMAN; IMAGE ANALYSIS; IMMUNOSUPPRESSIVE TREATMENT; KARNOFSKY PERFORMANCE STATUS; LEUKOPENIA; LYMPHOCYTOPENIA; MALE; MIDDLE AGED; MORPHOLOGY; MULTIPLE CYCLE TREATMENT; NERVOUS SYSTEM PARAMETERS; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLIGODENDROGLIOMA; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; RADIATION NECROSIS; SENSITIVITY AND SPECIFICITY; ADVERSE EFFECTS; BRAIN; BRAIN NEOPLASMS; DRUG EFFECTS; GLIOMA; METABOLISM; NECROSIS; PATHOLOGY; RADIATION INJURIES; RADIATION RESPONSE; RADIOSURGERY; SKULL IRRADIATION; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; BRAIN; BRAIN NEOPLASMS; CRANIAL IRRADIATION; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NECROSIS; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOSURGERY; TREATMENT OUTCOME;

EID: 84906937068     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-014-1453-y     Document Type: Article

References (36)

1. Glantz MJ, Burger PC, Friedman AH, Radtke RA, Massey EW, Schold SC Jr (1994) Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology 44:2020-2027 (Pubitemid 24349499)
2. Kohshi K, Imada H, Nomoto S, Yamaguchi R, Abe H, Yamamoto H (2003) Successful treatment of radiation-induced brain necrosis by hyperbaric oxygen therapy. J Neurol Sci 209:115-117 (Pubitemid 36398687)
3. McPherson CM, Warnick RE (2004) Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging. J Neurooncol 68:41-47
4. Presta LG, Chen H, O'Connor SJ, Chisholm V, Meng YG, Krummen L et al (1997) Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res 57:4593-4599 (Pubitemid 27441066)
5. Nordal RA, Nagy A, Pintilie M, Wong CS (2004) Hypoxia and hypoxia-inducible factor-1 target genes in central nervous system radiation injury: a role for vascular endothelial growth factor. Clin Cancer Res 15:3342-3353 (Pubitemid 38685439)
6. Nonoguchi N, Miyatake S, Fukumoto M, Furuse M, Hiramatsu R, Kawabata S et al (2011) The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles. J Neurooncol 105:423-431
7. Gonzalez J, Kumar AJ, Conrad CA, Levin VA (2007) Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 67:323-326 (Pubitemid 46108339)
8. Levin VA, Bidaut L, Hou P, Kumar AJ, Wefel JS, Bekele BN et al (2011) Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys 79:1487-1495
9. Furuse M, Kawabata S, Kuroiwa T, Miyatake S (2011) Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases. J Neurooncol 102:471-475
10. Torcuator R, Zuniga R, Mohan YS, Rock J, Doyle T, Anderson J et al (2009) Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol 94:63-68
11. Miwa K, Matsuo M, Shinoda J, Oka N, Kato T, Okumura A et al (2008) Simultaneous integrated boost technique by helical tomotherapy for the treatment of glioblastoma multiforme with 11Cmethionine PET: report of three cases. J Neurooncol 87:333-339
12. Matsuo M, Miwa K, Tanaka O, Shinoda J, Nishibori H, Tsuge Y et al (2012) Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning. Int J Radiat Oncol Biol Phys 82:83-89
13. Takenaka S, Asano Y, Shinoda J, Nomura Y, Yonezawa S, Miwa K, et al (2014) Comparison of 11C-methionine, 11C-choline, and 18F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis. Neurol Med Chir (Tokyo). 54(4):280-289
14. Shinoda J, Yano H, Ando H, Ohe N, Sakai N, Saio M et al (2002) Radiological response and histological changes in malignant astrocytic tumors after stereotactic radiosurgery. Brain Tumor Pathol 19:83-92 (Pubitemid 36356315)
15. Amin A, Moustafa H, Ahmed E, El-Toukhy M (2012) Glioma residual or recurrence versus radiation necrosis: accuracy of pentavalent technetium-99 m-di mercaptosuccinic acid [Tc-99 m (v) DMSA] brain SPECT compared to proton magnetic resonance spectroscopy (H1-MRS): initial results. J Neurooncol 106:579-587
16. Matoba M, Kondou T, Tanaka T, Kitadate M, Oota K, Tonami H (2010) Noninvasive monitoring of radiation-induced early therapeutic response using high-resolution MR imaging and proton MR spectroscopy in VX2 carcinoma. J Radiat Res 51:690-705
17. Nakajima T, Kumabe T, Kanamori M, Saito R, Tashiro R, Watanabe M et al (2009) Differential diagnosis between radiation necrosis and glioma progression using sequential proton magnetic resonance spectroscopy and methionine positron emission tomography. Neurol Med Chir (Tokyo) 49:394-401
18. Moravan MJ, Olschowka JA, Williams JP, O'Banion MK (2011) Cranial irradiation leads to acute and persistent neuroinflammation with delayed increases in T-cell infiltration and CD11c expression in C57BL/6 mouse brain. Radiat Res 176:459-473
19. Zhao W, Robbins ME (2009) Inflammation and chronic oxdative stress in radiation-induced late normal tissue injury: therapeutic implications. Curr Med Chem 16:130-143
20. Ogawa T, Shishido F, Kanno I, Inugami A, Fujita H, Murakami M et al (1993) Cerebral glioma: evaluation with methionine PET. Radiology 186:45-53 (Pubitemid 23005465)
21. 11C-methinone-PET. J Neurooncol 109:115-122
22. De Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M et al (2001) Positron emission tomography with injection of methionine as a prognostic factor in glioma. J Neurosurg 95:746-750 (Pubitemid 33043345)
23. 11C-methionine PET for differential diagnosis of low grade gliomas. Neurology 50:1316-1322
24. 11C-choline positron-emission tomography. AJNR Am J Neuroradiol 29:1176-1182
25. Nariai T, Tanaka Y, Wakimoto H, Aoyagi M, Tamaki M, Ishiwata K et al (2005) Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma. J Neurosurg 103:498-507 (Pubitemid 43186642)
26. 11C-methionine. AJNR Am J Neuroradiol 17:345-353
27. Tovi M, Lilja A, Bergström M, Ericsson A, Bergström K, Hartman M(1990) Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography. Acta Radiol 31:417-429
28. Ohtani T, Kurihara H, Ishiuchi S, Saito N, Oriuchi N, Inoue T et al (2001) Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging. Eur J Nucl Med 28:1664-1670 (Pubitemid 33036109)
29. Kureshi SA, Hofman FM, Schneider JH, Chin LS, Apuzzo ML, Hinton DR (1994) Cytokine expression in radiation-induced delayed cerebral injury. Neurosurgery 35:822-830 (Pubitemid 24338243)
30. Chiang CS, McBride WH, Withers HR (1993) Radiation-induced astrocytic and microglial responses in mouse brain. Radiother Oncol 29:60-68 (Pubitemid 23336820)
31. Tsuyuguchi N, Sunada I, Iwai Y, Yamanaka K, Tanaka K, Takami T et al (2003) Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? J Neurosurg 98:1056-1064 (Pubitemid 36460897)
32. Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE et al (2009) Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 27:4733-4740
33. Kreisl TN, Kim L, Moore K, Duic P, Royce C, Stroud I et al (2009) Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol 27:740-745
34. Lai A, Tran A, Nghiemphu PL, Pope WB, Solis OE, Selch M et al (2010) Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme. J Clin Oncol 29:142-148
35. Narayana A, Gruber D, Kunnakkat S, Golfinos JG, Parker E, Raza S et al (2012) A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma. J Neurosurg 116:341-345
36. Vredenburgh JJ, Desjardins A, Herndon JE II, Marcello J, Reardon DA, Quinn JA et al (2007) Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 25:4722-4729 (Pubitemid 350086473)